109 related articles for article (PubMed ID: 8018450)
1. The induction of murine tumor infiltrating lymphocytes (TIL) by interleukin-2 or T cell growth factor.
Kan N; Mise K; Nakanishi M; Okino T; Harada T; Ichinose Y; Moriguchi Y; Sugie T; Li L; Imamura M
Biotherapy; 1993; 6(4):303-9. PubMed ID: 8018450
[TBL] [Abstract][Full Text] [Related]
2. Effects of cytokines on in vitro growth of tumor-infiltrating lymphocytes obtained from human primary and metastatic liver tumors.
Shimizu Y; Iwatsuki S; Herberman RB; Whiteside TL
Cancer Immunol Immunother; 1991; 32(5):280-8. PubMed ID: 1847844
[TBL] [Abstract][Full Text] [Related]
3. Specific antitumor activity of tumor-infiltrating lymphocytes expanded first in a culture with both anti-CD3 monoclonal antibody and activated B cells and then in a culture with interleukin-2.
Tamada K; Harada M; Okamoto T; Takenoyama M; Ito O; Matsuzaki G; Nomoto K
Cancer Immunol Immunother; 1995 Dec; 41(6):339-47. PubMed ID: 8635191
[TBL] [Abstract][Full Text] [Related]
4. Characterization of interleukin-2-initiated versus OKT3-initiated human tumor-infiltrating lymphocytes from glioblastoma multiforme: growth characteristics, cytolytic activity, and cell phenotype.
Grimm EA; Bruner JM; Carinhas J; Köppen JA; Loudon WG; Owen-Schaub L; Steck PA; Moser RP
Cancer Immunol Immunother; 1991; 32(6):391-9. PubMed ID: 1848799
[TBL] [Abstract][Full Text] [Related]
5. The emergence of non-cytolytic NK1.1+ T cells in the long-term culture of murine tumour-infiltrating lymphocytes: a possible role of transforming growth factor-beta.
Tamada K; Harada M; Ito O; Takenoyama M; Mori T; Matsuzaki G; Nomoto K
Immunology; 1996 Dec; 89(4):627-35. PubMed ID: 9014832
[TBL] [Abstract][Full Text] [Related]
6. Intratumoral interleukin-2 immunotherapy: activation of tumor-infiltrating and splenic lymphocytes in vivo.
Dubinett SM; Patrone L; Tobias J; Cochran AJ; Wen DR; McBride WH
Cancer Immunol Immunother; 1993; 36(3):156-62. PubMed ID: 8382559
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-12 augments the generation of autologous tumor-reactive CD8+ cytotoxic T lymphocytes from tumor-infiltrating lymphocytes.
Kuge S; Watanabe K; Makino K; Tokuda Y; Mitomi T; Kawamura N; Habu S; Nishimura T
Jpn J Cancer Res; 1995 Feb; 86(2):135-9. PubMed ID: 7730135
[TBL] [Abstract][Full Text] [Related]
8. Regulatory effects of interleukin-4 on tumor-infiltrating lymphocytes derived from human renal cell carcinoma.
Peyret C; Bochner BH; Lee TY; Koo AS; deKernion JB; Belldegrun A
J Surg Res; 1992 Dec; 53(6):602-9. PubMed ID: 1494294
[TBL] [Abstract][Full Text] [Related]
9. Antitumor effector mechanism of interleukin-1 beta at a distant site in the double grafted tumor system.
Ebina T; Murata K
Jpn J Cancer Res; 1991 Nov; 82(11):1292-8. PubMed ID: 1752785
[TBL] [Abstract][Full Text] [Related]
10. [Adoptive immunotherapy and metastasized cancer of the kidney. Regulator effects of interleukin-4 on tumor infiltrating lymphocytes (TIL)].
Peyret C; Bochner B; Lee TY; Tso CL; Dekernion JB; Belldegrun A
Chirurgie; 1991; 117(9):700-9. PubMed ID: 1843670
[TBL] [Abstract][Full Text] [Related]
11. [The antitumor effects of tumor-infiltrating lymphocytes (TIL) being proliferated in vitro].
Zhang BX
Zhonghua Bing Li Xue Za Zhi; 1992 Apr; 21(2):79-81. PubMed ID: 1499075
[TBL] [Abstract][Full Text] [Related]
12. The in vitro effects of interleukin-12 upon tumor-infiltrating lymphocytes derived from renal cell carcinoma.
Steger GG; Gnant MF; Djavanmard MP; Mader RM; Jakesz R; Pierce W; deKernion JB; Figlin R; Belldegrun A
J Cancer Res Clin Oncol; 1997; 123(6):317-24. PubMed ID: 9222297
[TBL] [Abstract][Full Text] [Related]
13. Inoculation of human interleukin-17 gene-transfected Meth-A fibrosarcoma cells induces T cell-dependent tumor-specific immunity in mice.
Hirahara N; Nio Y; Sasaki S; Minari Y; Takamura M; Iguchi C; Dong M; Yamasawa K; Tamura K
Oncology; 2001; 61(1):79-89. PubMed ID: 11474253
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-2 expanded lymphocytes from lymph node and tumor biopsies of human renal cell carcinoma, breast and ovarian cancer.
Bouet-Toussaint F; Genetel N; Rioux-Leclercq N; Bansard JY; Levêque J; Guillé F; Patard JJ; Lesimple T; Catros-Quemener V
Eur Cytokine Netw; 2000 Jun; 11(2):217-24. PubMed ID: 10903800
[TBL] [Abstract][Full Text] [Related]
15. Phenotypical and functional differences of tumor-infiltrating lymphocytes from human colorectal cancers induced by costimulation with rIL-2 and rIL-4 in vitro.
Keller H; Wimmenauer S; Rahner S; Von Kleist S; Farthmann EH
Anticancer Res; 1996; 16(6B):3565-70. PubMed ID: 9042222
[TBL] [Abstract][Full Text] [Related]
16. Advantages of adoptive chemoimmunotherapy with polyethylene glycol-cultured, antigen-activated, tumor-infiltrated spleen cells for the complete eradication of lethal MOPC-315 plasmacytomas.
Laude M; Siessmann KL; Mokyr MB; Dray S
Cancer Res; 1991 Sep; 51(17):4516-22. PubMed ID: 1873795
[TBL] [Abstract][Full Text] [Related]
17. [Tumor-specific cytotoxicity of tumor infiltrating lymphocytes (TIL) induced with TCGF in murine mammary carcinoma].
Hori T; Kan N; Ohgaki K; Yamazaki N; Nakayama N; Nio Y; Inamoto T
Nihon Geka Gakkai Zasshi; 1984 Aug; 85(8):749-57. PubMed ID: 6238229
[TBL] [Abstract][Full Text] [Related]
18. Autologous tumor-specific cytotoxicity of tumor-infiltrating lymphocytes derived from human renal cell carcinoma.
Koo AS; Tso CL; Shimabukuro T; Peyret C; deKernion JB; Belldegrun A
J Immunother (1991); 1991 Oct; 10(5):347-54. PubMed ID: 1790142
[TBL] [Abstract][Full Text] [Related]
19. Patterns of cytokine release of unselected and CD8+ selected renal cell carcinoma tumor-infiltrating lymphocytes (TIL). Evidence for enhanced specific killing of tumor necrosis factor-secreting/IL-6 nonsecreting TIL in vitro and correlation with complete response in vivo.
Steger GG; Pierce WC; Figlin R; Czernin J; Kaboo R; DeKernion JB; Okarma T; Belldegrun A
Clin Immunol Immunopathol; 1994 Aug; 72(2):237-47. PubMed ID: 8050198
[TBL] [Abstract][Full Text] [Related]
20. Effect of indomethacin on tumor-infiltrating lymphocytes of a spontaneously developed murine mammary adenocarcinoma.
Chao TY; Chu TM
Cancer Immunol Immunother; 1989; 30(3):158-64. PubMed ID: 2598184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
